Glyburide Tablet
Product Images NDC 68382-656
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Glyburide (NDC 68382-656). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Zydus Pharmaceuticals (usa) Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure (Glyburidetabs Figure 02)
This is the description:
GlyBURIDE Tablets, USP with 125mg Gyoure, USP per tablet are available in a bottle of 100 tablets. It is an Rx only drug and must be stored at USP controlled room temperature. The complete prescribing information is available on the package insert. The drug should be kept out of children's reach. It is manufactured by Caa HeathareLi in India and distributed by Zytus Pharmaceuticals USA Inc. in Penmingion, NJ 06534.*
Figure (Glyburidetabs Figure 03)
NDC 68382-657-01 is a prescription drug named GlyBURIDE that comes in tablets form with a quantity of 100 tablets per package. Each tablet contains 25mg of Gyourde, USP. The suggested dosage is provided in the package insert. The medication should be stored at a temperature of 20°10 to 25°C (68 to 77°F) as per the USP-controlled room temperature. The drug should be dispensed only in the container suggested by the USP and kept out of reach of children. The medicine is manufactured by Caa Healthcare Ltd in India and distributed by Zytus Pharmaceuticals USA Inc. in Pennington, NJ 06534.*
Figure (Glyburidetabs Figure 04)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.